All Posts
CTSI director appointed co-chair of CTSA program steering committee
Duane Mitchell, M.D., Ph.D., has been appointed as co-chair of the Clinical and Translational Science Awards, or CTSA, Program Steering Committee.
UF researcher’s goal: Tackle HPV vaccine skepticism, access in rural North Central Florida
Stephanie Staras, M..S.P.H., Ph.D., a researcher and University of Florida faculty member, aims to reduce HPV related cancer risk by addressing multiple barriers to vaccination in rural areas with the help of a $4 million, five-year National Institutes of Health grant that began in September 2022.
Meet Bailey
Bailey is a 5-year-old Golden-doodle and has been a therapy dog for the past three years. She visits UF Health Shands and the CRC every other week to bring smiles to patients and hospital staff.
Mendy Dunn, MSN, RN, named CTSI associate director of clinical research
“Mendy” Elizabeth C. Dunn, MSN, RN has been named the Associate Director of Clinical Research. Dunn will oversee CTSI’s service center and clinical research center. In this role, she will support investigators and their associates by developing and improving services offered by the CTSI. In her previous role…
DC3 chair presents “Justice Fueled Change” at ACTS
CTSI associate director and director of its Diversity and Cultural Competence Council, Tiffany Danielle Chisholm Pineda, leads a presentation on justice-fueled change in this ACTS Professional Development Roundtable.
2018 – 2019 TDDC Publications
Publications from 2018 - 2019 that highlight research that was conducted with the support of the CTSI's Translational Drug Development Core.
2020 – 2022 TDDC Publications
Publications from 2020 - 2022 that highlight research that was conducted with the support of the CTSI's Translational Drug Development Core.
CTSI director featured with UF brain tumor team on ESPN
During The V Foundation for Cancer Research’s “V Week,” ESPN and ABC have aired videos highlighting UF Health’s efforts to fight brain cancer.
UF scientists repair genetic cause of ALS and dementia
Scientists at UF Scripps Biomedical Research have developed a potential medicine for a leading cause of ALS and dementia that works by eliminating disease-causing segments of RNA. The compound restored the health of neurons in the lab and rescued mice with the disease.
